Tabbatarwa...
An fassara ta atomatik. Don yawan magani da gargaɗi: duba asalin Turanci. Karanta da Turanci
Gida / Rijista a Najeriya / Cycloserine Capsules USP 250 mg

Cycloserine Capsules USP 250 mg

NAFDAC Reg. A'a. A4-100095 · Magungunan miyagun ƙwayoyi

Rijista tare da NAFDAC. Rijista mai aikiAs of 2 November 2026 · synced automatically from official sources.
Product
Cycloserine Capsules USP 250 mg
NAFDAC number
A4-100095
Active ingredient
Cycloserine
Strength
250 mg
Form
Capsule
Pack size
1 x 10's, 10 x 10's (in blisters), 1 x 100's (in HDPE container)
Manufacturer
Not listed
Applicant (holder)
Healthline Limited
Approved
28 Sep 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
27 Sep 2026
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Cycloserine: uses, dosage and brands worldwide

What we found

  • Cycloserine Capsules USP 250 mg is on the NAFDAC register with an active registration (A4-100095). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Cycloserine Capsules USP 250 mg

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. Like all antituberculosis drugs, cycloserine should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. Cycloserine may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram-positive and gram- negative bacteria. …

How to take it and how often
  • Cycloserine is effective orally and is currently administered only by this route
  • The usual dosage is 500 mg to 1 g daily in divided doses monitored by blood levels. 1 The initial adult dosage most frequently given is 250 mg twice daily at 12-hour intervals for the first 2 weeks
  • A daily dosage of 1 g should not be exceeded
Talk to a doctor first if

Administration is contraindicated in patients with any of the following: • Hypersensitivity to cycloserine • Epilepsy • Depression, severe anxiety, or psychosis • Severe renal insufficiency • Excessive concurrent use of alcoho

Warnings

Administration of cycloserine should be discontinued or the dosage reduced if the patient develops allergic dermatitis or symptoms of CNS toxicity, such as convulsions, psychosis, somnolence, depression, confusion, hyperreflexia, headache, tremor, vertigo paresis, or dysarthria. The toxicity of cycloserine is closely related to excessive blood levels (above 30 mcg/mL), as determined by high dosage or inadequate renal clearance. The ratio of toxic dose to effective dose in tuberculosis is small. The risk of convulsions is increased in chronic alcoholics. Patients should be monitored by hematologic, renal excretion, blood level, and liver function studies.

Possible side effects

Most adverse reactions occurring during therapy with cycloserine involve the nervous system or are manifestations of drug hypersensitivity. The following side effects have been observed in patients receiving cycloserine: Nervous system symptoms (which appear to be related to higher dosages of the drug, i.e., more than 500 mg daily) • Convulsions • Drowsiness and somnolence • Headache • Tremor • Dysarthria • Vertigo • Confusion and disorientation with loss of memory • Psychoses, possibly with suicidal tendencies • Character changes • Hyperirritability • Aggression • Paresis • Hyperreflexia • Paresthesia • Major & minor (localized) clonic seizures • Coma Cardiovascular: Sudden development of c …

If you take too much

Signs and Symptoms: Acute toxicity from cycloserine can occur if more than 1 g is ingested by an adult. Chronic toxicity from cycloserine is dose related and can occur if more than 500 mg is administered daily. The central nervous system is the most common organ system involved with toxicity. Toxic effects may include headache, vertigo, confusion, drowsiness, hyperirritability, paresthesias, dysarthria, psychosis paresis, convulsions, and coma. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-07-30.

Label for cycloserine, the active ingredient registered with NAFDAC.

Check your pack of Cycloserine Capsules USP 250 mg

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Cycloserine Capsules USP 250 mg

What is in Cycloserine Capsules USP 250 mg?

Cycloserine Capsules USP 250 mg contains Cycloserine (250 mg), as capsule, according to its NAFDAC registration record.

Is Cycloserine Capsules USP 250 mg registered with NAFDAC?

Yes. Cycloserine Capsules USP 250 mg is listed on the NAFDAC register under registration number A4-100095, and its registration is active as of 2 November 2026.

Has Cycloserine Capsules USP 250 mg been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Cycloserine Capsules USP 250 mg in our automatically synced alert list.

How can I check that my pack of Cycloserine Capsules USP 250 mg is genuine?

Run a free authenticity scan with the NAFDAC number A4-100095, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Cycloserine Capsules USP 250 mg?

Follow your prescription or the leaflet in your pack. The official label says: Cycloserine is effective orally and is currently administered only by this route. The usual dosage is 500 mg to 1 g daily in divided doses monitored by blood levels. 1 The initial adult dosage most frequently given is 250 mg twice daily at 12-hour intervals for the first 2 weeks. A daily dosage of 1 g should not be exceeded.…

What is Cycloserine Capsules USP 250 mg used for?

Cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. Like all antituberculosis drugs, cycloserine should be administered in conjunction with other effec (Summarised from the official U.S. FDA label for cycloserine. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Cycloserine Capsules USP 250 mg? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.